Brought to you by:
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular disparities award
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to a patient’s race said the findings speak “to an injustice within the field of vascular surgery.” The research…
Intraoperative vascular mapping during hemodialysis access ‘should be incorporated into routine practice’
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin, MD, associate professor of surgery at the Zucker School of Medicine at Hofstra/Northwell in Lake Success, New York, concluded at the…
VentureMed completes enrollment of Flex Vessel Prep system randomized controlled trial in arteriovenous fistulas
VentureMed Group recently announced that it has completed enrollment of a randomized controlled trial (RCT) entitled “Flex Vessel Prep prior to PTA for the treatment of obstructive lesions in the native AVF.” This RCT was conducted to assess primary patency…
Amplifi vein dilation system demonstrates ‘encouraging’ clinical results in hemodialysis access
Artio Medical announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium (Nov. 16–20, Orlando) by Surendra Shenoy, MD, associate professor of surgery in the Washington University School of…
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term data suggesting it offers an “excellent alternative” to AVF creation via surgical procedures in end-stage renal…
Fist Assist device achieves significant perforator vein dilation for improved endoAVF placement, p-FACT cohort data show
Fist Assist Devices has announced that data associated with the p-FACT cohort, a subset of the recently completed, non-significant risk Fist Assist clinical trial (FACT trial) that focused on vein dilation in stage four patients with chronic renal failure, show clear…
#SVSTweetChat hits high levels of engagement
Since the inaugural #SVSTweetChat that covered early career advice went live on Twitter in April, the monthly social media initiative has proven to be a valuable and interactive resource for the vascular surgeon community. It even inspired an episode of…
Risk of ‘feared’ ischemic steal syndrome comparable for tapered and non-tapered AVGs
In a recent systematic review and meta-analysis, Venkata Sai Jasty, from the University of Arizona College of Medicine in Tuscon, Arizona, and colleagues found that the risk of ischemic steal syndrome, “one of the most feared complications in vascular access,”…
Ultrasound-guided PTA is a ‘valuable tool’ in vascular access stenosis
Routine ultrasound-guided percutaneous transluminal angioplasty (PTA) is a feasible treatment for native arteriovenous fistula (AVF) dysfunction, according to a recent study by Antonio Granata, MD, of “Cannizzaro” Hospital, Catania, Italy. The findings were published online on 25 July in the…